Dermex Pharmaceutical, Inc. — Form D
Dermex Pharmaceutical, Inc. of ENGLEWOOD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-13. The offering totals $300K, of which $25K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-12-13
- Form: D
- Accession: 0001564270-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $300K
- Amount sold: $25K
- Remaining: $275K
- Minimum investment: $10K
- Investors: 2
- Date of first sale: 2012-12-03
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-188294
Issuer
- Name: Dermex Pharmaceutical, Inc.
- CIK: 0001564270
- Entity type: Corporation
- Jurisdiction: COLORADO
- Address: 14550 EAST EASTER AVEUNE, ENGLEWOOD, CO, 80112
- Phone: 303-358-0371
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Dan Cleveland, Jr | Director | Englewood, CO |
| Carl Hanson | Director | Englewood, CO |
| Frank Potestio, II | Director | Englewood, CO |
| Carl Hanson | Executive Officer | Englewood, CO |
| Frank Potestio, II | Executive Officer | Englewood, CO |
| Michael Solhaug | Executive Officer | Englewood, CO |
More